AKTX: Akari Therapeutics Plc
2020-01-10 09:30:09
Akari Therapeutics Announces Positive Interim Data from Phase III Paroxysmal Nocturnal Hemoglobinuria (PNH) Study
A lot of folks have been asking me regarding the idea around NASDAQ:AKTX setup. So instead of repeating myself over twitter and other places, I am going to post some DD behind my thesis in case you find it useful.
Currently, stock trades around $2 mark so w/ ~15M shares in the OS, the market cap is ~$30M. As a point of reference, co has their lead asset...
This therapeutics company has been known for high marks in the historical volatility department, but now that it's up so high on volume and it's particularly volatile now it could be a good time to short it. NASDAQ:AKTX
